A complaint was filed by Ventria Bioscience Inc. with the U.S. International Trade Commission alleging violations of section 337 of the Tariff Act of 1930. The complaint concerns the importation and sale of plant-derived recombinant human serum albumins (rHSA) and related products, which allegedly infringe upon certain U.S. patents and are falsely designated in origin. The U.S. International Trade Commission has initiated an investigation and will determine whether to issue exclusion and cease and desist orders against the respondents named in the complaint.
Simple Explanation
A company thinks some other people are bringing in special plant-made proteins without permission and pretending they made them. Now, a big rule-checking group is looking into it to see if they should stop those people from doing it.